1. What Happened? Q1 2025 Earnings Breakdown

EZCaretech’s Q1 2025 revenue reached 15.924 billion KRW, a 17.26% decrease year-over-year. Operating profit plummeted by 81.58% to 111 million KRW. Declining sales to major domestic hospitals and a sharp drop in overseas revenue are cited as the primary culprits. The 51.91% plunge in overseas sales is particularly worrisome.

2. Why the Decline? Unpacking the Underperformance

The revenue decline stems primarily from fewer projects with large domestic hospitals and struggles in the overseas market. The drop in operating profit was largely driven by increased SG&A expenses (up 36.09%) due to new business investments, increased R&D spending, and personnel expansion. However, the significant discrepancy between the standalone operating profit and the consolidated figure (11.132 billion KRW) warrants further investigation.

3. What’s Next? Future Outlook and Investment Considerations

While short-term downward pressure on the stock price is likely, the 11.93% growth in the SM (operation and maintenance) segment is a positive sign. In the mid-to-long term, R&D investments in new solutions and securing competitiveness in the cloud HIS market are expected to drive growth. The company also needs to overcome declining sales and improve profitability through successful overseas market penetration and new business ventures. Investors should closely monitor overseas market recovery, new business performance, cost efficiency improvements, and efforts to reduce reliance on major clients.

4. What Should Investors Do? Action Plan

Despite short-term challenges, EZCaretech retains long-term growth potential. However, investors should carefully consider the uncertainties in the overseas market, dependence on major clients, and the effectiveness of R&D investments before making any decisions. Continuously monitoring future earnings releases and the performance of key business segments is crucial for adjusting investment strategies.